← All companies
SMMT annual net income
Summit Therapeutics Inc.
SMMT - CIK 0001599298
Market cap$10.13 B
Rank#935
SEC filings532
Summit Therapeutics Inc. net income by year
Summit Therapeutics Inc. (SMMT) reported net income of -$1.08B for fiscal year 2025, as filed in its audited annual report with the SEC.
SMMT net income 2018-2025
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$1.08B | -387.8% |
| FY 2024 | -$221.31M | +64.0% |
| FY 2023 | -$614.93M | -680.5% |
| FY 2022 | -$78.78M | +11.1% |
| FY 2021 | -$88.60M | -68.1% |
| FY 2020 | -$52.70M | -80.9% |
| FY 2019 | -$29.13M | -368.0% |
| FY 2019 | $10.87M | +141.2% |
| FY 2018 |
Net Income of similar companies
Frequently asked questions
How much profit does Summit Therapeutics Inc. make?
Summit Therapeutics Inc. (SMMT) reported net income of -$1.08B for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Summit Therapeutics Inc.'s net income changed over time?
Between fiscal 2018 and fiscal 2025, Summit Therapeutics Inc.'s net income declined from -$26.35M to -$1.08B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.